Lupin Appoints Dr. Ranjana Pathak As Chief Quality Officer

With over three decades of industry experience, Dr. Pathak brings a wealth of expertise and leadership and will oversee all aspects of quality and regulatory compliance for Lupin’s global operations.

Dr. Pathak’s career includes serving as the Global Head for Quality and Pharmacovigilance at Dr. Reddy’s. Prior to this, Dr. Pathak served as the President & Global Head of Quality, Medical Affairs and Pharmacovigilance at Cipla and has also held Global Quality and Compliance leadership positions at Watson/Actavis and Endo Pharmaceuticals in the U.S. Dr. Pathak has strong experience across generic and brand medicines across dosage platforms including injectables, inhalation products and biologics.

“We extend our gratitude to Johnny for his valuable contribution to Lupin over the past five years,” said Vinita Gupta, CEO and Nilesh Gupta, MD, Lupin. “We are delighted to welcome Ranjana to our executive leadership team. Her extensive global experience and proven track record in building and sustaining a strong culture of quality and compliance align with Lupin’s commitment to be best-in-class in delivering quality products to the communities we serve.”